AndroGel and Nicotine Interaction Profile: What TRT Patients Who Smoke Need to Know

At a glance

  • Direct interaction / Not listed for a testosterone gel 1.62% product [1]
  • Nicotine's metabolism / CYP2A6 substrate [6]
  • Smoke's enzyme effect / CYP1A2 induction, attributed to smoke not nicotine [2][3]
  • Shared cardiovascular effect / Both raise blood pressure [4][5]
  • Combined blood pressure effect / Not established
  • Hematocrit checks (label) / Before treatment, 3 to 6 months after starting, then annually [1]
  • Gel effect on hematocrit / Mean rise of 3.0% vs placebo in a network meta-analysis of 29 trials [7]

Is There a Direct Interaction Between AndroGel and Nicotine?

Nicotine and testosterone gel are not known to interact directly. For a testosterone gel 1.62% product, the prescribing information's drug interactions section names insulin, oral anticoagulants and corticosteroids; nicotine and tobacco are not named there [1]. That label is not the AndroGel brand label, and topical testosterone products can differ in dose, strength and application instructions [1].

Nicotine is a substrate of CYP2A6 [6]. The enzyme induction that makes cigarette smoking change levels of other drugs is attributed to polycyclic aromatic hydrocarbons in tobacco smoke acting on CYP1A2; nicotine itself is not the inducer [2][3]. The smoking interactions that prompt dose changes are with CYP1A2 substrates such as caffeine, clozapine, olanzapine and theophylline [2][3].

The combined effect of smoking, nicotine replacement or vaping with testosterone gel has not been tested.

Does It Matter Where the Nicotine Comes From?

Nicotine replacement delivers nicotine without tobacco smoke. A review of smoking cessation states that the hepatic enzyme effect is not related to the nicotine component of tobacco, so nicotine replacement will not alter it [3]. When a person quits smoking, CYP1A2 induction reverses, which can raise levels of drugs such as clozapine and theophylline [3].

A nicotine patch uses the skin, but the gel's drug interactions section does not address transdermal nicotine [1]. The gel label says to apply it to clean, dry, intact skin of the shoulders and upper arms, and not to the abdomen, genitals, chest, armpits or knees [1].

Blood Pressure: Where Smoking and Testosterone Gel Overlap

Nicotine causes peripheral vasoconstriction, tachycardia and higher blood pressure, and tolerance does not develop to its catecholamine-releasing effects [4]. Testosterone raises blood pressure too: FDA's review of ambulatory blood pressure studies confirmed an increase with all testosterone products, class-wide [5].

In TRAVERSE, a randomized, double-blind, placebo-controlled trial of 5,246 men with hypogonadism and existing or high cardiovascular risk, mean systolic pressure rose 1.0 mm Hg on daily 1.62% testosterone gel versus a 0.5 mm Hg fall on placebo at 36 months [1][8]. That gel's prescribing information says it can increase blood pressure and is not recommended in men with uncontrolled hypertension, and it advises monitoring blood pressure periodically, especially in men with hypertension [1].

Hematocrit and Clot Risk

Testosterone raises hematocrit. In a network meta-analysis of 29 placebo-controlled randomized trials with 3,393 men, gel raised mean hematocrit by 3.0% versus placebo [7]. For the 1.62% gel, the label says to check hematocrit before starting, re-evaluate it 3 to 6 months after starting and then annually, and to stop therapy until hematocrit decreases to an acceptable concentration if it becomes elevated; it notes that an increase in red blood cell mass may increase the risk of thromboembolic events [1]. That section does not single out smokers [1].

Venous thromboembolism, including deep vein thrombosis and pulmonary embolism, has been reported with testosterone products. In TRAVERSE, VTE occurred in 1.7% of men on gel versus 1.2% on placebo [1]. Smoking increases blood coagulability, while transdermal nicotine does not appear to [9].

Does Smoking Change Testosterone Levels?

Observational data run against the idea that smoking lowers testosterone. In NHANES III (1,275 men), current smokers had higher geometric mean total testosterone than never-smokers (5.42 versus 5.26 ng/mL) and higher free testosterone (0.110 versus 0.104 ng/mL) [10]. In the Tromsø study (1,563 men), total and free testosterone were positively associated with tobacco consumption, and SHBG was positively associated with smoking [11]. Both studies measured the body's own testosterone, not levels achieved from a gel.

What Should a Smoker Using Testosterone Gel Watch For?

Nicotine and testosterone products can each raise blood pressure, but their combined effect has not been tested [4][5]. The testosterone gel 1.62% label says to measure blood pressure periodically and to check hematocrit on the schedule above [1]. It also says to evaluate leg pain, swelling, warmth and redness, or sudden shortness of breath, for a possible clot, and to monitor serum testosterone, PSA, hemoglobin, hematocrit, liver function tests and lipids periodically [1].

Frequently asked questions

Is AndroGel safe to use if I smoke?
The prescribing information for a testosterone gel 1.62% product does not list nicotine or tobacco as drug interactions [1]. That is not the AndroGel brand label, and topical testosterone products differ in dose, strength and application instructions [1]. Nicotine can raise blood pressure [4], and testosterone products raise blood pressure class-wide [5].
Does smoking speed up how the body clears testosterone gel?
The testosterone gel 1.62% interactions section, which names insulin, oral anticoagulants and corticosteroids, does not describe a smoking effect on the gel [1]. The enzyme induction attributed to smoking is CYP1A2, and it comes from polycyclic aromatic hydrocarbons in smoke rather than nicotine [2][3]. The CYP1A2 drugs named in reviews of smoking interactions include caffeine, clozapine, olanzapine and theophylline [2][3].
Can I use a nicotine patch with testosterone gel?
The gel's drug interactions section does not address transdermal nicotine [1]. The gel label says to apply it to the shoulders and upper arms and not to the abdomen, chest, armpits, genitals or knees [1]. Nicotine replacement does not alter the CYP1A2 effect of tobacco smoke [3], and nicotine is a CYP2A6 substrate [6].
Does quitting smoking change my testosterone dose?
The interactions section of the testosterone gel 1.62% label does not mention smoking or quitting [1]. Quitting reverses CYP1A2 induction and can raise levels of CYP1A2 drugs such as clozapine and theophylline [3].
Does smoking lower testosterone?
Observational data point the other way. In NHANES III (1,275 men), current smokers had higher geometric mean total testosterone than never-smokers (5.42 versus 5.26 ng/mL) and higher free testosterone (0.110 versus 0.104 ng/mL) [10]. The Tromsø study (1,563 men) found total and free testosterone positively associated with tobacco consumption [11].
What hematocrit level is too high on testosterone gel?
The testosterone gel 1.62% label says to stop therapy until hematocrit decreases to an acceptable concentration if it becomes elevated; its polycythemia section gives no single numeric cutoff [1]. A network meta-analysis of 29 trials found gel raised mean hematocrit by 3.0% versus placebo [7].

References

  1. U.S. National Library of Medicine, DailyMed. Testosterone gel 1.62% topical (Padagis) prescribing information. Testosterone gel 1.62% topical, generic (Padagis) label
  2. Kroon LA. Drug interactions with smoking. Am J Health Syst Pharm. 2007;64(18):1917-21. Drug interactions with smoking
  3. Schaffer SD, Yoon S, Zadezensky I. A review of smoking cessation: potentially risky effects on prescribed medications. J Clin Nurs. 2009;18(11):1533-40. A review of smoking cessation: potentially risky effects on prescribed medications
  4. Zevin S, Benowitz NL. Drug interactions with tobacco smoking. An update. Clin Pharmacokinet. 1999;36(6):425-38. Drug interactions with tobacco smoking. An update
  5. FDA issues class-wide labeling changes for testosterone products | FDA. FDA issues class-wide labeling changes for testosterone products | FDA
  6. Anderson GD, Chan LN. Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products. Clin Pharmacokinet. 2016;55(11):1353-1368. Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products
  7. Nackeeran S, Kohn T, Gonzalez D, White J, Ory J, Ramasamy R. The Effect of Route of Testosterone on Changes in Hematocrit: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Trials. J Urol. 2022;207(1):44-51. The Effect of Route of Testosterone on Changes in Hematocrit: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Trials
  8. Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023;389(2):107-117. Cardiovascular Safety of Testosterone-Replacement Therapy
  9. Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol. 1997;29(7):1422-31. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy
  10. Shiels MS, Rohrmann S, Menke A, Selvin E, Crespo CJ, Rifai N, et al. Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US men. Cancer Causes Control. 2009;20(6):877-86. Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US men
  11. Svartberg J, Midtby M, Bønaa KH, Sundsfjord J, Joakimsen RM, Jorde R. The associations of age, lifestyle factors and chronic disease with testosterone in men: the Tromsø Study. Eur J Endocrinol. 2003;149(2):145-52. The associations of age, lifestyle factors and chronic disease with testosterone in men: the Tromsø Study
Evidence overview for AndroGel and Nicotine Interaction Profile: What TRT Patients Who Smoke Need to Know